Mdxhealth Sa Revenue Growth Rates (MDXH), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Mdxhealth Sa  (NASDAQ: MDXH)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

MDXH's Revenue Growth by Quarter and Year

Mdxhealth Sa's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MDXH Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December 107.88
3rd Quarter September 0.00
2nd Quarter June 0.00
1st Quarter March 0.00
FY 107.88

MDXHs Annual Revenue
Mdxhealth Sa's Revenue in the fiscal year 2025 $ 107.88 millions
Mdxhealth Sa's Revenue in the fiscal year 2024 $ 90.05 millions
Mdxhealth Sa's Revenue in the fiscal year 2023 $ 70.19 millions
Mdxhealth Sa's Revenue in the fiscal year 2022 $ 37.05 millions
Mdxhealth Sa's Revenue in the fiscal year 2021 $ 22.24 millions




MDXH Revenue fourth quarter 2025 Y/Y Growth Comment
Mdxhealth Sa reported Revenue rise of 53.69% year on year in the fourth quarter 2025, to $ 107.88 millions, this is lower than Mdxhealth Sa's recent average Revenue rise of 78.03%.

Among companies who have reported fourth quarter 2025 results in the Medical Laboratories industry only one Company has achieved higher year on year Revenue results in the fourth quarter 2025. While Mdxhealth Sa' s Revenue jump of 53.69% ranks overall at the positon no. 167 in the fourth quarter 2025.


MDXH Revenue ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter December 53.69 % 89.45 % 66.59 % -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   53.69 % 89.45 % 66.59 % -

Financial Statements
Mdxhealth Sa's fourth quarter 2025 Revenue $ 107.88 millions MDXH's Income Statement
Mdxhealth Sa's fourth quarter 2024 Revenue $ 70.19 millions Quarterly MDXH's Income Statement


MDXH Revenue (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   53.69 % 89.45 % 66.59 % -


Back to MDXH Growth rate Comparisons >> Back to MDXH Growth rate Comparisons >>


Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #2
Healthcare Sector #54
Overall #167

Revenue Y/Y Growth Statistics
High Average Low
89.43 % 78.03 % 66.62 %
(Dec 31 2023)   (Dec 31 2022)
Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #2
Healthcare Sector #54
Overall #167
Revenue Y/Y Growth Statistics
High Average Low
89.43 % 78.03 % 66.62 %
(Dec 31 2023)   (Dec 31 2022)

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Mdxhealth Sa's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


MDXH's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


MDXH's IV. Quarter Q/Q Revenue Comment


Mdxhealth Sa's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Dec 31 2022)		 12 Months Ending
Cumulative Revenue 12 Months Ending $ 107.88 $ 90.05 $ 70.19 $ 37.05 $ 0.00
Y / Y Revenue Growth (TTM) 19.8 % 28.29 % 89.43 % 66.62 % -
Year on Year Revenue Growth Overall Ranking # 167 # 256 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 19.8 % 28.29 % 89.43 % 66.62 % -
Seq. Revenue Growth (TTM) Overall Ranking # 167 # 256 # 0 # 0 # 0


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Dec 31 2025 period, Mdxhealth Sa's cumulative twelve months Revenue were $ 108 millions, company would post below average annual Revenue growth of 66.62% year on year, if the fiscal year would end at Dec 31 2025.
A slow-down in the Mdxhealth Sa's Revenue growth from the 0% growth in Dec 31 2024. Comparing the results with it's peers in Medical Laboratories industry, Mdxhealth Sa's trailing twelve months Revenue growth, were the second highest.

In the Healthcare sector 53 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 167, from total ranking in previous quarter at 256.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 2
Healthcare Sector # 54
Overall # 167

Revenue TTM Y/Y Growth Statistics
High Average Low
89.43 %
 78.03 %
66.62 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 54
S&P 500 # 167
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Dec 31 2025 period, Mdxhealth Sa's cumulative twelve months Revenue were $ 108 millions, company would post below average annual Revenue growth of 66.62% year on year, if the fiscal year would end at Dec 31 2025.
A slow-down in the Mdxhealth Sa's Revenue growth from the 0% growth in Dec 31 2024. Comparing the results with it's peers in Medical Laboratories industry, Mdxhealth Sa's trailing twelve months Revenue growth, were the second highest.

In the Healthcare sector 53 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 167, from total ranking in previous quarter at 256.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 2
Healthcare Sector # 54
Overall # 167

Revenue TTM Y/Y Growth Statistics
High Average Low
89.43 %
78.03 %
66.62 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 54
S&P 500 # 167




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
MDXH's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue jump for the quarter ending Dec 31 2025 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2025
Tenon Medical Inc 92.34%$ 92.338 millions
Caribou Biosciences Inc 89.74%$ 89.745 millions
Argenx Se89.08%$ 89.078 millions
Sangamo Therapeutics Inc 88.43%$ 88.425 millions
Agios Pharmaceuticals Inc 86.09%$ 86.086 millions
Oculis Holding Ag85.72%$ 85.722 millions
Alnylam Pharmaceuticals Inc 84.95%$ 84.945 millions
Day One Biopharmaceuticals Inc 83.92%$ 83.915 millions
Neuronetics Inc 82.17%$ 82.169 millions
Arcutis Biotherapeutics Inc 81.48%$ 81.478 millions
Aclarion Inc 80.59%$ 80.590 millions
X4 Pharmaceuticals Inc79.08%$ 79.079 millions
Intellia Therapeutics Inc 78.79%$ 78.787 millions
Envoy Medical Inc 78.57%$ 78.571 millions
Organogenesis Holdings Inc 78.13%$ 78.126 millions
Tg Therapeutics Inc 78.00%$ 78.004 millions
Eton Pharmaceuticals Inc 77.14%$ 77.140 millions
Trisalus Life Sciences Inc 76.95%$ 76.954 millions
Co diagnostics Inc 76.74%$ 76.743 millions
Ss Innovations International Inc76.54%$ 76.537 millions
Cellectis S a 75.76%$ 75.760 millions
Fennec Pharmaceuticals Inc 73.84%$ 73.842 millions
Travere Therapeutics Inc 73.41%$ 73.410 millions
Inspiremd Inc 69.30%$ 69.299 millions
Viridian Therapeutics Inc 68.06%$ 68.056 millions
Sol gel Technologies Ltd 68.04%$ 68.036 millions
Novavax inc 66.61%$ 66.615 millions
Beyond Air Inc 65.61%$ 65.605 millions
Axsome Therapeutics Inc 65.03%$ 65.030 millions
Kiniksa Pharmaceuticals International Plc64.95%$ 64.953 millions


About Mdxhealth Sa Revenue Growth Rates (MDXH), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Mdxhealth Sa (CIK 1872529).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001213900-26-039540
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Mdxhealth Sa’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.